R-bPiDI, an Α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement

Neurochemical Research- United States

doi 10.1007/s11064-015-1680-4

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Acute & Subchronic NMDA Receptor Blockade Alters Nicotine-Evoked Dopamine Release

English

Novel Bis-, Tris-, and Tetrakis-Tertiary Amino Analogs as Antagonists at Neuronal Nicotinic Receptors That Mediate Nicotine-Evoked Dopamine Release

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2011English

Ventral Tegmental Area Α6β2 Nicotinic Acetylcholine Receptors Modulate Phasic Dopamine Release in the Nucleus Accumbens Core

Psychopharmacology
Pharmacology
2013English

Habenular Signaling in Nicotine Reinforcement

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2011German

Nicotine Reinforcement in Never-Smokers

Psychopharmacology
Pharmacology
2015English

Brain Regions Mediating Α3β4 Nicotinic Antagonist Effects of 18-Mc on Nicotine Self-Administration

European Journal of Pharmacology
Pharmacology
2011English

Anatabine Significantly Decreases Nicotine Self-Administration

Drug and Alcohol Dependence
PsychiatryToxicologyMental HealthPharmacology
2014English

Interactive Effects of the mGlu5 Receptor Antagonist MPEP and the mGlu2/3 Receptor Antagonist LY341495 on Nicotine Self-Administration and Reward Deficits Associated With Nicotine Withdrawal in Rats

European Journal of Pharmacology
Pharmacology
2007English

Multiple Cholinergic Nicotinic Receptor Genes Affect Nicotine Dependence Risk in African and European Americans

Genes, Brain and Behavior
NeurologyGeneticsBehavioral Neuroscience
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy